Middle East & Africa Small Molecule Drug Discovery Market Overview, Growth, Trends, Analysis, Research Report (2023-2031)

The Middle East & Africa Small Molecule Drug Discovery Market size is expected to reach US$ 1,215.7 Million by 2031 from US$ 632.4 Million in 2023. The market is estimated to record a CAGR of 8.6% from 2023 to 2031.

Executive Summary and Middle East & Africa Small Molecule Drug Discovery Market Analysis:

The Middle East & African (MEA) small molecule drug discovery market is divided into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The market in this region is experiencing steady growth based on a number of factors. An increasing prevalence of cancer and other chronic diseases has developed a strong demand for innovative therapeutic solutions, prompting more attention towards the development of small molecule drugs. Along with this, increasing investment in the health and pharma sector-both by government agencies and private sector investors-is creating the momentum of innovation and enhancing research infrastructure in the region. Joint ventures with organizations and research institutions of developed economies are also driving technology growth and knowledge exchange faster. The UAE and Saudi Arabia are taking the lead with strategic projects aimed at developing drug discovery infrastructure, while South Africa is poised to become a major center for clinical research. All these developments combined are set to drive the MEA small molecule drug discovery market forward in the next few years.

Middle East & Africa Small Molecule Drug Discovery Market: Strategic Insights

Middle East & Africa Small Molecule Drug Discovery Market Segmentation Analysis:

• By Therapeutic Area, the Middle East & Africa Small Molecule Drug Discovery Market is segmented into Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas. Oncology held the largest share of the market in 2023.
• By Process or Phase, the Middle East & Africa Small Molecule Drug Discovery Market is segmented into Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development. Lead Generation and Refinement held the largest share of the market in 2023.

Middle East & Africa Small Molecule Drug Discovery Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Small Molecule Drug Discovery Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East & Africa Small Molecule Drug Discovery Market Outlook

Artificial intelligence (AI) and associated technologies assist in making drug discovery cost-effective and derive quick results. It helps by offering innovative ways to collect and manage data, along with reducing dependency on manual operations. Leading biopharmaceutical companies are utilizing AI platforms to accelerate the drug discovery. For instance, Pfizer uses IBM Watson (a machine learning system) to enhance its search for immuno-oncology drugs. With the rapid introduction of AI in healthcare, numerous pharmaceutical companies are investing in joint ventures with AI companies for the identification of drug targets and designing new drugs. Therefore, numerous partnerships between pharmaceutical industries, AI companies, and government organizations are rising globally. For instance, in 2023, Merck partnered with BenevolentAI and Exscientia to harness the power of AI-driven design and discovery capabilities, further advancing the company's research efforts. Moreover, in November 2023, Evommune Inc. partnered with Accutar Biotechnology Inc, and focused on the discovery of novel small molecule drug candidates in chronic inflammatory diseases. The collaboration is expected to leverage Accutar's proprietary AI platform as well as Evommune's expertise in the design and development of novel oral small molecule treatments against the root cause of chronic immune-mediated inflammatory diseases. Thus, AI-driven drug discovery is emerging as a significant trend in the small molecule drug discovery market.

Middle East & Africa Small Molecule Drug Discovery Market Country Insights

By country, the Middle East & Africa Small Molecule Drug Discovery Market is segmented into Saudi Arabia, the United Arab Emirates, South Africa, Rest of Middle East & Africa. Saudi Arabia held the largest share in 2023.

Saudi Arabia is the largest economy in the Middle East. The country is highly focused on providing improved healthcare services, and public organizations and the government are initiating programs to support the progress of various research activities. In the last few years, the private sector has actively invested in the healthcare system in Saudi Arabia. Further, the Government of Saudi Arabia launched the Saudi Vision 2031 program to diversify its economy and reduce dependence on the oil and gas sector. The subsequent progress of the healthcare sector is leading to significant improvements in healthcare services, supported by the adoption of advanced technologies. Moreover, medical R&D and clinical trials play an important role in improving healthcare, directly benefiting patients, and making the latest pharmaceutical advancements accessible to a broader pool of patients in Saudi Arabia.

An increasing incidence rate of cancer has been observed in Saudi Arabia, increasing the death count. According to the American Society of Clinical Oncology Journal article "Cancer Research Challenges and Potential Solutions in Saudi Arabia: A Qualitative Discussion Group Study," in Saudi Arabia, the number of new cancer cases was 27,885 in 2020 and is expected to rise to 60,429 by 2040. Several players have expanded their business in the market through acquisitions, mergers, partnerships, and other strategic alliances. Owing to the increasing incidences of chronic diseases and advancements made in the pharmaceutical sector, small molecule drug discovery is gaining traction, as these are considered to be a new approach to treating various life-threatening diseases.

Middle East & Africa Small Molecule Drug Discovery Market Company Profiles

Some of the key players operating in the market include GSK Plc, Charles River Laboratories International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Merck KGaA, ICON Plc, Revvity Inc., Danaher Corp, Thermo Fisher Scientific Inc., Oncodesign Services.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Small Molecule Drug Discovery Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise